ADARB2 and glioblastoma: As shown in Table 2, ADAR3 expression was an independent prognostic indicator for the OS of LGG patients in CGGA dataset (Table 3, HR, 0.419; 95% CI, 0.289–0.608; P < 0.001), but not for the OS of GBM patients (Table 3, HR, 0.804; 95% CI, 0.556–1.163; P = 0.247).